Hematology - Stanford researchers develop a portable device for rapidly detecting blood ammonia levels
Can't see this email? View it online
   
  Hematology  
  The latest hematology news from News Medical  
 Dual inhibitor therapy may be safer for patients with chronic lymphocytic leukemiaDual inhibitor therapy may be safer for patients with chronic lymphocytic leukemia
 
Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. One in four new leukemia cases are CLL.
 
   Stanford researchers develop a portable device for rapidly detecting blood ammonia levelsStanford researchers develop a portable device for rapidly detecting blood ammonia levels
 
Seated around the dinner table, faculty affiliated with Stanford ChEM-H - one of Stanford University's interdisciplinary institutes - spoke one-by-one, pitching ideas for collaborative research.
 
   New immunotherapy for metastatic non-small cell lung cancer shows promise in clinical trialNew immunotherapy for metastatic non-small cell lung cancer shows promise in clinical trial
 
A new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being tested by Missak Haigentz, Jr., MD, medical director of hematology and oncology for Atlantic Health System.
 
 Study finds more effective treatment for children with sickle cell anemia
 
Study finds more effective treatment for children with sickle cell anemiaA team of international researchers has learned that dose escalation of hydroxyurea treatment for children in Uganda with sickle cell anemia is more effective and has similar side effects than a lower fixed dose of the same drug.
 
 
 Takeda provides updates on its pharmacokinetic-guided prophylaxis studies at ISTH 2020, reinforcing its commitment to advancing personalized care for people with bleeding disorders
 
Takeda provides updates on its pharmacokinetic-guided prophylaxis studies at ISTH 2020, reinforcing its commitment to advancing personalized care for people with bleeding disordersTakeda Pharmaceutical Company Limited today announced that 13 abstracts are being presented from the company’s Hematology portfolio and pipeline at the International Society on Thrombosis and Haemostasis 2020 Virtual Congress.
 
 
 New nanoconjugate blocks dissemination of tumor cells in animal models of acute myeloid leukemia
 
New nanoconjugate blocks dissemination of tumor cells in animal models of acute myeloid leukemiaThe nanoparticle targets only leukemic cells and therefore would reduce the severe adverse effects of current treatments.